- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
33 result(s) found for: Epithelialization.
Displaying page 1 of 2.
| EudraCT Number: 2010-019945-24 | Sponsor Protocol Number: BEB-10 | Start Date*: 2010-09-24 |
| Sponsor Name:Birken GmbH | ||
| Full Title: Open, Prospective, Controlled Case series Documentation to Compare Intra-individually the Efficacy and Tolerance of Sericare versus Non-adhesive Wound Dressing alone in Accelerating the Epitheliali... | ||
| Medical condition: This is an open, prospective, controlled case-series documentation to compare intra-individually the efficacy and tolerance of Sericare versus standard treatment in accelerating the epithelializati... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-017418-56 | Sponsor Protocol Number: BSH-10 | Start Date*: 2010-04-07 |
| Sponsor Name:Birken GmbH | ||
| Full Title: Open, Prospective, Controlled, Randomised, Multicenter Phase II Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Moist Wound Healing Dressing alone in A... | ||
| Medical condition: Es handelt sich um eine offene, prospektive, kontrollierte, randomisierte, multizentrische Studie der Phase II, die eine intra-individuelle Wirksamkeit und Verträglichkeit des Oleogel-S10 mit einer... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002461-21 | Sponsor Protocol Number: TBRU-dS-BC-PIIb | Start Date*: 2018-10-29 |
| Sponsor Name:CUTISS AG | ||
| Full Title: A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for th... | ||
| Medical condition: Children with partial deep dermal and full thickness burns | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002460-41 | Sponsor Protocol Number: TBRU-dS-BA-PIIb | Start Date*: 2018-10-29 |
| Sponsor Name:CUTISS AG | ||
| Full Title: A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for th... | ||
| Medical condition: Adults and adolescents with partial deep dermal and full thickness burns | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000361-78 | Sponsor Protocol Number: HTA-HUR-01 | Start Date*: 2020-12-01 |
| Sponsor Name:HOLOSTEM TERAPIE AVANZATE S.R.L. | ||
| Full Title: PROSPECTIVE, OPEN-LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED ORAL MUCOSA GRAFTS FOR URETHRAL RECONSTRUCTION IN PATIENTS DUE TO HYPOSPADIAS TREATMENT... | ||
| Medical condition: Urethral reconstruction in patients due to hypospadias treatment failure. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male | |
| Trial protocol: IT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000308-12 | Sponsor Protocol Number: P150941J | Start Date*: 2020-11-06 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS | |||||||||||||
| Full Title: « Mesenchymal stromal cells treatment in Lyell syndrome: A pilot phase 1-2 open trial” | |||||||||||||
| Medical condition: Patients: Adults diagnosed with SJS-TEN with at least 10% of body surface area involved. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-019887-35 | Sponsor Protocol Number: ABH-DERMAGRAFT-001-09 | Start Date*: 2010-09-06 | |||||||||||
| Sponsor Name:Advanced BioHealing Inc | |||||||||||||
| Full Title: A Prospective, Multi-center, Longitudinal Cohort Study of Dermagraft® in Subjects with Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial | |||||||||||||
| Medical condition: Venous leg ulcers | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) EE (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-002462-41 | Sponsor Protocol Number: TBRU-dS-RAC-PII | Start Date*: 2018-10-29 |
| Sponsor Name:CUTISS AG | ||
| Full Title: A Phase II, prospective, intra-patient randomized controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the... | ||
| Medical condition: Adults and children with full thickness skin defects | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002180-41 | Sponsor Protocol Number: DSC127-2012-01 | Start Date*: 2015-07-29 |
| Sponsor Name:Derma Sciencs Inc | ||
| Full Title: A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Aclerastide (DSC127) in Treating Non-healing Foot Ulcers in Subjects wit... | ||
| Medical condition: Diabetic Foot Ulcers | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: LV (Prematurely Ended) LT (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-002321-10 | Sponsor Protocol Number: PR11/2022 | Start Date*: 2023-01-16 | |||||||||||||||||||||||||||||||
| Sponsor Name:Hospital Universitari d'Igualada | |||||||||||||||||||||||||||||||||
| Full Title: Effectiveness and safety of topical sevoflurane for the treatment of painful skin ulcers; randomized, double-blind, placebo-controlled clinical trial | |||||||||||||||||||||||||||||||||
| Medical condition: Cutaneous complex ulcers (grade II, III and IV) which are painful and require hospital care | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-001380-13 | Sponsor Protocol Number: PROPADB-01 | Start Date*: 2014-08-08 |
| Sponsor Name:Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran | ||
| Full Title: Effects of the treatment with propranolol in the burnt adult intubated patient with sinusal tachycardia induced by burns. | ||
| Medical condition: BURNT-INDUCED SINUSAL TACHYCARDIA | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002819-60 | Sponsor Protocol Number: FAC-BOTOX | Start Date*: 2021-08-19 |
| Sponsor Name:Hospital Universitario de Burgos | ||
| Full Title: Treatment of chronic anal fissure with ultrasound-guided intersphincteric infiltration of botulinum toxin A. | ||
| Medical condition: Chronic anal fissure | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000362-38 | Sponsor Protocol Number: BBW-11 | Start Date*: 2012-06-18 | |||||||||||
| Sponsor Name:Birken AG | |||||||||||||
| Full Title: Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Standard of Care in... | |||||||||||||
| Medical condition: Superficial partial-thickness (grade 2a) burn wounds | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) SE (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-002196-15 | Sponsor Protocol Number: DSC127-2012-02 | Start Date*: 2015-07-29 |
| Sponsor Name:Derma Sciencs Inc | ||
| Full Title: A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Aclerastide (DSC127) in Treating Non-healing Foot U... | ||
| Medical condition: Diabetic Foot Ulcers | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: LV (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003627-54 | Sponsor Protocol Number: 150601 | Start Date*: 2016-05-11 | |||||||||||
| Sponsor Name:Tecnimede, Sociedade Técnico-Medicinal, S.A. | |||||||||||||
| Full Title: Randomized, multicenter, placebo-controlled, double blind study to assess the efficacy and tolerability of 2% diltiazem hydrochloride in the treatment of chronic anal fissure and a 24 week follow-u... | |||||||||||||
| Medical condition: Cronic Anal fissure (CAF) The underlying pathogenesis of chronic anal fissure involves initial local trauma (generally caused by hard stools), resulting in a wound, internal anal sphincter spasm an... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-000968-42 | Sponsor Protocol Number: PRPZDSKIN | Start Date*: 2016-06-23 |
| Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
| Full Title: Study on the healing of the partial skin graft donor site in burn patients after application of platelet-rich plasma (PRP) or plasma rich in growth factors versus usual therapeutical practice. | ||
| Medical condition: Study on healing the graft donor skin on burn patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001178-28 | Sponsor Protocol Number: FISPAC-2011 | Start Date*: 2012-09-05 |
| Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
| Full Title: Multicentre, randomized, comparative and Add-on, in two parallel groups to assess the efficacy and safety of autologous mesenchymal stem cells derived from expanded adipose tissue (ASC) for the tre... | ||
| Medical condition: Local treatment in complex perianal fistulas in patients without inflammatory bowel disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003042-16 | Sponsor Protocol Number: IIBSP-PTE-2018-35 | Start Date*: 2019-02-08 |
| Sponsor Name:Institut de Recerca H. de la Santa Creu i Sant Pau | ||
| Full Title: Randomized clinical trial to evaluate the efficacy of fibrin membrane graft with eye drops concentrated in autologous growth factors in primary pterygium surgery comparing it with amniotic membrane... | ||
| Medical condition: Pterigyum | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-006013-11 | Sponsor Protocol Number: HOTPANTS | Start Date*: 2022-08-29 |
| Sponsor Name:Erasmus MC, department of dermatology | ||
| Full Title: Hyperbaric Oxygen Therapy for Pyoderma gangrenosum As a New Treatment Strategy | ||
| Medical condition: Pyoderma gangrenosum | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004592-74 | Sponsor Protocol Number: HOLOGENE7(HTA-HG7-01) | Start Date*: 2016-06-01 |
| Sponsor Name:Holostem Terapie Avanzate s.r.l. | ||
| Full Title: PROSPECTIVE, OPEN LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED EPIDERMAL GRAFTS CONTAINING EPIDERMAL STEM CELLS GENETICALLY MODIFIED WITH A GAMMA-RETR... | ||
| Medical condition: RDEB is characterized by generalized skin blistering, erosions, crusts, atrophic scarring, onychodystrophy and loss of nails, mutilating pseudosyndactyly of hands and feet, as well as oral cavity l... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
